Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer

Cancer Letters

Volumn 360, Issue 2, 2015, Pages 141-150

  Cao, Yang ^a   Liu, Xiyong ^b   Lu, Wei ^a,c   Chen, Yuanyuan ^a   Wu, Xiangsong ^a   Li, Maolan ^a   Wang, Xu an ^a   Zhang, Fei ^a   Jiang, Lin ^a   Zhang, Yijian ^a   Hu, Yunping ^a   Xiang, Shanshan ^a   Shu, Yijun ^a   Bao, Runfa ^a   Li, Huaifeng ^a   Wu, Wenguang ^a   Weng, Hao ^a   Yen, Yun ^b   Liu, Yingbin ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Fibronectin; Gallbladder cancer; Invasion; MTOR; Proliferation

Indexed keywords

CYCLIN D1; FIBRONECTIN; FOCAL ADHESION KINASE; GELATINASE B; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN KINASE B; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FEMALE; GALLBLADDER CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR INVASION; UPREGULATION; VERY ELDERLY; ANIMAL; BIOSYNTHESIS; CELL MOTION; GALLBLADDER TUMOR; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SECONDARY; TUMOR CELL LINE; XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; FIBRONECTINS; GALLBLADDER NEOPLASMS; HETEROGRAFTS; HUMANS; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84924903308     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.01.041     Document Type: Article

References (37)

1. Pola C., Formenti S.C., Schneider R.J. Vitronectin-alphavbeta3 integrin engagement directs hypoxia-resistant mTOR activity and sustained protein synthesis linked to invasion by breast cancer cells. Cancer Res 2013, 73:4571-4578.
2. Nguyen-Ngoc K.V., Cheung K.J., Brenot A., Shamir E.R., Gray R.S., Hines W.C., et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2595-E2604.
3. Li M., Zhang Z., Li X., Ye J., Wu X., Tan Z., et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat. Genet 2014, 46:872-876.
4. Bae Y.K., Kim A., Kim M.K., Choi J.E., Kang S.H., Lee S.J. Fibronectin expression in carcinoma cells correlates with tumor aggressiveness and poor clinical outcome in patients with invasive breast cancer. Hum. Pathol 2013, 44:2028-2037.
5. Ma L.J., Lee S.W., Lin L.C., Chen T.J., Chang I.W., Hsu H.P., et al. Fibronectin overexpression is associated with latent membrane protein 1 expression and has independent prognostic value for nasopharyngeal carcinoma. Tumour Biol 2014, 35:1703-1712.
6. Jagadeeshan S., Krishnamoorthy Y.R., Singhal M., Subramanian A., Mavuluri J., Lakshmi A., et al. Transcriptional regulation of fibronectin by p21-activated kinase-1 modulates pancreatic tumorigenesis. Oncogene 2015, 34:455-464.
7. Sen T., Dutta A., Maity G., Chatterjee A. Fibronectin induces matrix metalloproteinase-9 (MMP-9) in human laryngeal carcinoma cells by involving multiple signaling pathways. Biochimie 2010, 92:1422-1434.
8. Han S., Sidell N., Roman J. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett 2005, 219:71-81.
9. Knowles L.M., Gurski L.A., Engel C., Gnarra J.R., Maranchie J.K., Pilch J. Integrin alphavbeta3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis. Cancer Res 2013, 73:6175-6184.
10. Nam J.M., Onodera Y., Bissell M.J., Park C.C. Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. Cancer Res 2010, 70:5238-5248.
11. Chen C.Y., Lin X.Z., Tsao H.C., Shiesh S.C. The value of biliary fibronectin for diagnosis of cholangiocarcinoma. Hepatogastroenterology 2003, 50:924-927.
12. Korner T., Kropf J., Hackler R., Brenzel A., Gressner A.M. Fibronectin in human bile fluid for diagnosis of malignant biliary diseases. Hepatology 1996, 23:423-428.
13. Wang Z., Zheng T., Wu Q., Wang J., Wu C., Wang J. Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma. Neoplasma 2012, 59:137-141.
14. No J.H., Jeon Y.T., Park I.A., Kim Y.B., Kim J.W., Park N.H., et al. Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. Gynecol. Oncol 2011, 121:8-12.
15. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004, 18:1926-1945.
16. Kyou Kwon J., Kim S.J., Hoon Kim J., Mee Lee K., Ho Chang I. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer. Urol. Oncol 2014, 32:51.e27-51.e35.
17. Nishi T., Iwasaki K., Ohashi N., Tanaka C., Kobayashi D., Nakayama G., et al. Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells. Cancer Lett 2013, 331:220-229.
18. Leal P., Garcia P., Sandoval A., Letelier P., Brebi P., Ili C., et al. Immunohistochemical expression of phospho-mTOR is associated with poor prognosis in patients with gallbladder adenocarcinoma. Arch. Pathol. Lab. Med 2013, 137:552-557.
19. Leal P., Garcia P., Sandoval A., Buchegger K., Weber H., Tapia O., et al. AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines. Onco Targets Ther 2013, 6:1373-1384.
20. Zong H., Yin B., Zhou H., Cai D., Ma B., Xiang Y. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition. Mol. Biol. Rep 2014, 41:4507-4512.
21. Li M., Lu J., Zhang F., Li H., Zhang B., Wu X., et al. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway. Cancer Lett 2014, 355:201-209.
22. Han L., Wang W., Lu J., Kong F., Ma G., Zhu Y., et al. AAV-sBTLA facilitates HSP70 vaccine-triggered prophylactic antitumor immunity against a murine melanoma pulmonary metastasis model in vivo. Cancer Lett 2014, 354:398-406.
23. Meng X.N., Jin Y., Yu Y., Bai J., Liu G.Y., Zhu J., et al. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br. J. Cancer 2009, 101:327-334.
24. Zeng Z.Z., Jia Y., Hahn N.J., Markwart S.M., Rockwood K.F., Livant D.L. Role of focal adhesion kinase and phosphatidylinositol 3'-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res 2006, 66:8091-8099.
25. Zhao Y., Min C., Vora S.R., Trackman P.C., Sonenshein G.E., Kirsch K.H. The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J. Biol. Chem 2009, 284:1385-1393.
26. Zeller K.S., Idevall-Hagren O., Stefansson A., Velling T., Jackson S.P., Downward J., et al. PI3-kinase p110alpha mediates beta1 integrin-induced Akt activation and membrane protrusion during cell attachment and initial spreading. Cell. Signal 2010, 22:1838-1848.
27. Chen H.C., Appeddu P.A., Isoda H., Guan J.L. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem 1996, 271:26329-26334.
28. Rowinsky E.K. Targeting the molecular target of rapamycin (mTOR). Curr. Opin. Oncol 2004, 16:564-575.
29. Bullock M.D., Mellone M., Pickard K.M., Sayan A.E., Mitter R., Primrose J.N., et al. Molecular profiling of the invasive tumor microenvironment in a 3-dimensional model of colorectal cancer cells and ex vivo fibroblasts. J. Vis. Exp 2014, 10.3791/51475.
30. Mathias R.A., Chen Y.S., Wang B., Ji H., Kapp E.A., Moritz R.L., et al. Extracellular remodelling during oncogenic Ras-induced epithelial-mesenchymal transition facilitates MDCK cell migration. J. Proteome Res 2010, 9:1007-1019.
31. Sameni M., Dosescu J., Yamada K.M., Sloane B.F., Cavallo-Medved D. Functional live-cell imaging demonstrates that beta1-integrin promotes type IV collagen degradation by breast and prostate cancer cells. Mol. Imaging 2008, 7:199-213.
32. Kamoshida G., Matsuda A., Miura R., Takashima Y., Katsura A., Tsuji T. Potentiation of tumor cell invasion by co-culture with monocytes accompanying enhanced production of matrix metalloproteinase and fibronectin. Clin. Exp. Metastasis 2013, 30:289-297.
33. Jiao Y., Feng X., Zhan Y., Wang R., Zheng S., Liu W., et al. Matrix metalloproteinase-2 promotes alphavbeta3 integrin-mediated adhesion and migration of human melanoma cells by cleaving fibronectin. PLoS ONE 2012, 7:e41591.
34. Kenny H.A., Kaur S., Coussens L.M., Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J. Clin. Invest 2008, 118:1367-1379.
35. Maity G., Fahreen S., Banerji A., Roy Choudhury P., Sen T., Dutta A., et al. Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa). Mol. Cell. Biochem 2010, 336:65-74.
36. Das S., Banerji A., Frei E., Chatterjee A. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci 2008, 82:467-476.
37. Sil H., Sen T., Chatterjee A. Fibronectin-integrin (alpha5beta1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9. Oncol. Res 2011, 19:335-348.